Uploaded July 2026 | Updated September 2026, 3 weeks ago
Professor Teresa Lambe OBE, Pandemic Sciences and Oxford Vaccine Group, talks about the ChAdOx1 BDBV vaccine, in what is the world's first in-human trial of a Bundibugyo ebolavirus vaccine. The first vaccination of a participant in the trial took place in Oxford on Friday 24 July 2026. Read more about the trial here: ox.ac.uk/news/2026-07-24-first-volunteer-vaccinated-in-the-worlds-first-bundibugyo-ebolavirus-vaccine-trial
Professor Teresa Lambe OBE, Pandemic Sciences and Oxford Vaccine Group, talks about the ChAdOx1 BDBV vaccine, in what is the world's first in-human trial of a Bundibugyo ebolavirus vaccine. The first vaccination of a participant in the trial took place in Oxford on Friday 24 July 2026. Read more about the trial here: ox.ac.uk/news/2026-07-24-first-volunteer-vaccinated-in-the-worlds-first-bundibugyo-ebolavirus-vaccine-trial










